Current clinical applications of in vivo gene therapy with AAVs

JR Mendell, SA Al-Zaidy, LR Rodino-Klapac… - Molecular Therapy, 2021 - cell.com
Hereditary diseases are caused by mutations in genes, and more than 7,000 rare diseases
affect over 30 million Americans. For more than 30 years, hundreds of researchers have …

Viral vectors in gene therapy: where do we stand in 2023?

K Lundstrom - Viruses, 2023 - mdpi.com
Viral vectors have been used for a broad spectrum of gene therapy for both acute and
chronic diseases. In the context of cancer gene therapy, viral vectors expressing anti-tumor …

Phenoty** and genoty** inherited retinal diseases: Molecular genetics, clinical and imaging features, and therapeutics of macular dystrophies, cone and cone-rod …

M Georgiou, AG Robson, K Fu**ami… - Progress in retinal and …, 2024 - Elsevier
Inherited retinal diseases (IRD) are a leading cause of blindness in the working age
population and in children. The scope of this review is to familiarise clinicians and scientists …

Inherited retinal diseases: Therapeutics, clinical trials and end points—A review

M Georgiou, K Fu**ami… - Clinical & Experimental …, 2021 - Wiley Online Library
Inherited retinal diseases (IRDs) are a clinically and genetically heterogeneous group of
disorders characterised by photoreceptor degeneration or dysfunction. These disorders …

Pharmaceutical development of AAV-based gene therapy products for the eye

GA Rodrigues, E Shalaev, TK Karami… - Pharmaceutical …, 2019 - Springer
A resurgence of interest and investment in the field of gene therapy, driven in large part by
advances in viral vector technology, has recently culminated in United States Food and Drug …

[HTML][HTML] In vivo imaging of human cone photoreceptor inner segments

D Scoles, YN Sulai, CS Langlo… - … & visual science, 2014 - jov.arvojournals.org
Purpose.: An often overlooked prerequisite to cone photoreceptor gene therapy
development is residual photoreceptor structure that can be rescued. While advances in …

[HTML][HTML] Progress in treating inherited retinal diseases: early subretinal gene therapy clinical trials and candidates for future initiatives

AV Garafalo, AV Cideciyan, E Héon, R Sheplock… - Progress in retinal and …, 2020 - Elsevier
Due to improved phenoty** and genetic characterization, the field of 'incurable'and
'blinding'inherited retinal diseases (IRDs) has moved substantially forward. Decades of …

Human retinal gene therapy for Leber congenital amaurosis shows advancing retinal degeneration despite enduring visual improvement

AV Cideciyan, SG Jacobson, WA Beltran… - Proceedings of the …, 2013 - pnas.org
Leber congenital amaurosis (LCA) associated with retinal pigment epithelium-specific
protein 65 kDa (RPE65) mutations is a severe hereditary blindness resulting from both …

Gene therapy for inherited retinal diseases: progress and possibilities

ML Hu, TL Edwards, F O'Hare, DG Hickey… - Clinical and …, 2021 - Taylor & Francis
Inherited retinal diseases (IRDs) comprise a heterogeneous group of genetic disorders
affecting the retina. Caused by mutations in over 300 genes, IRDs result in visual impairment …

[HTML][HTML] The genetics of normal and defective color vision

J Neitz, M Neitz - Vision research, 2011 - Elsevier
The contributions of genetics research to the science of normal and defective color vision
over the previous few decades are reviewed emphasizing the developments in the 25years …